Cedars-Sinai Health Ventures, the Los Angeles-based health system’s venture capital arm, led a $6 million series A funding round for cardiac data company RhythmScience, per Becker’s.
The startup analyzes data from tens of thousands of cardiology patients, from such health systems as University of Chicago Medicine and Houston Methodist, to create standardized data aimed at curtailing missed diagnoses and unnecessary hospitalizations. The platform also tracks cardiac implants, wearables and weight scales in one portal.
